nodes	percent_of_prediction	percent_of_DWPC	metapath
Nedocromil—HSP90AA1—pons—peripheral nervous system neoplasm	0.0306	0.305	CbGeAlD
Nedocromil—PTGDR—trigeminal ganglion—peripheral nervous system neoplasm	0.02	0.2	CbGeAlD
Nedocromil—HSP90AA1—ganglion—peripheral nervous system neoplasm	0.0157	0.156	CbGeAlD
Nedocromil—CYSLTR1—trigeminal ganglion—peripheral nervous system neoplasm	0.00886	0.0884	CbGeAlD
Nedocromil—HSP90AA1—trigeminal ganglion—peripheral nervous system neoplasm	0.00769	0.0767	CbGeAlD
Nedocromil—HSP90AA1—parotid gland—peripheral nervous system neoplasm	0.00725	0.0724	CbGeAlD
Nedocromil—HSP90AA1—brainstem—peripheral nervous system neoplasm	0.0068	0.0679	CbGeAlD
Nedocromil—HSP90AA1—cerebellum—peripheral nervous system neoplasm	0.00335	0.0335	CbGeAlD
Nedocromil—Cough—Topotecan—peripheral nervous system neoplasm	0.00178	0.00362	CcSEcCtD
Nedocromil—Cough—Tretinoin—peripheral nervous system neoplasm	0.00177	0.00359	CcSEcCtD
Nedocromil—Cough—Isotretinoin—peripheral nervous system neoplasm	0.00177	0.00359	CcSEcCtD
Nedocromil—Stinging—Doxorubicin—peripheral nervous system neoplasm	0.00175	0.00356	CcSEcCtD
Nedocromil—Pharyngitis—Alitretinoin—peripheral nervous system neoplasm	0.00175	0.00355	CcSEcCtD
Nedocromil—Cough—Melphalan—peripheral nervous system neoplasm	0.00174	0.00354	CcSEcCtD
Nedocromil—Chest pain—Topotecan—peripheral nervous system neoplasm	0.00174	0.00353	CcSEcCtD
Nedocromil—Dysphonia—Doxorubicin—peripheral nervous system neoplasm	0.00173	0.00351	CcSEcCtD
Nedocromil—Chest pain—Tretinoin—peripheral nervous system neoplasm	0.00172	0.0035	CcSEcCtD
Nedocromil—Chest pain—Isotretinoin—peripheral nervous system neoplasm	0.00172	0.0035	CcSEcCtD
Nedocromil—Chest pain—Melphalan—peripheral nervous system neoplasm	0.0017	0.00345	CcSEcCtD
Nedocromil—Viral infection—Epirubicin—peripheral nervous system neoplasm	0.0017	0.00345	CcSEcCtD
Nedocromil—Visual impairment—Alitretinoin—peripheral nervous system neoplasm	0.0017	0.00345	CcSEcCtD
Nedocromil—Dry mouth—Isotretinoin—peripheral nervous system neoplasm	0.00168	0.00342	CcSEcCtD
Nedocromil—Dry mouth—Tretinoin—peripheral nervous system neoplasm	0.00168	0.00342	CcSEcCtD
Nedocromil—Cough increased—Epirubicin—peripheral nervous system neoplasm	0.00168	0.00341	CcSEcCtD
Nedocromil—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00166	0.00338	CcSEcCtD
Nedocromil—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00165	0.00336	CcSEcCtD
Nedocromil—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00165	0.00336	CcSEcCtD
Nedocromil—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00163	0.00331	CcSEcCtD
Nedocromil—Conjunctivitis—Cisplatin—peripheral nervous system neoplasm	0.00163	0.0033	CcSEcCtD
Nedocromil—Viral infection—Doxorubicin—peripheral nervous system neoplasm	0.00157	0.00319	CcSEcCtD
Nedocromil—Cough increased—Doxorubicin—peripheral nervous system neoplasm	0.00155	0.00315	CcSEcCtD
Nedocromil—Pneumonia—Etoposide—peripheral nervous system neoplasm	0.00154	0.00313	CcSEcCtD
Nedocromil—HSP90AA1—Semaphorin interactions—ERBB2—peripheral nervous system neoplasm	0.0015	0.00367	CbGpPWpGaD
Nedocromil—Dyspnoea—Topotecan—peripheral nervous system neoplasm	0.00148	0.00302	CcSEcCtD
Nedocromil—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.00148	0.00301	CcSEcCtD
Nedocromil—HSP90AA1—VEGFR2 mediated vascular permeability—AKT1—peripheral nervous system neoplasm	0.00148	0.00362	CbGpPWpGaD
Nedocromil—Dyspnoea—Tretinoin—peripheral nervous system neoplasm	0.00147	0.00299	CcSEcCtD
Nedocromil—Dyspnoea—Isotretinoin—peripheral nervous system neoplasm	0.00147	0.00299	CcSEcCtD
Nedocromil—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.00147	0.00298	CcSEcCtD
Nedocromil—FPR1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.00146	0.00359	CbGpPWpGaD
Nedocromil—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.00145	0.00295	CcSEcCtD
Nedocromil—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.00145	0.00295	CcSEcCtD
Nedocromil—Dyspnoea—Melphalan—peripheral nervous system neoplasm	0.00145	0.00295	CcSEcCtD
Nedocromil—Visual impairment—Cisplatin—peripheral nervous system neoplasm	0.00145	0.00294	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.00144	0.00292	CcSEcCtD
Nedocromil—Tremor—Alitretinoin—peripheral nervous system neoplasm	0.00144	0.00292	CcSEcCtD
Nedocromil—HSP90AA1—VEGFR1 specific signals—AKT1—peripheral nervous system neoplasm	0.00144	0.00352	CbGpPWpGaD
Nedocromil—Fatigue—Topotecan—peripheral nervous system neoplasm	0.00144	0.00292	CcSEcCtD
Nedocromil—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00143	0.00292	CcSEcCtD
Nedocromil—HSP90AA1—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	0.00143	0.00351	CbGpPWpGaD
Nedocromil—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.00143	0.0029	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.00143	0.0029	CcSEcCtD
Nedocromil—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.00142	0.00289	CcSEcCtD
Nedocromil—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00142	0.00289	CcSEcCtD
Nedocromil—Pain—Topotecan—peripheral nervous system neoplasm	0.00142	0.00289	CcSEcCtD
Nedocromil—PTGDR—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.00141	0.00347	CbGpPWpGaD
Nedocromil—Pain—Tretinoin—peripheral nervous system neoplasm	0.00141	0.00287	CcSEcCtD
Nedocromil—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00141	0.00287	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.00141	0.00286	CcSEcCtD
Nedocromil—Fatigue—Melphalan—peripheral nervous system neoplasm	0.00141	0.00286	CcSEcCtD
Nedocromil—Pain—Melphalan—peripheral nervous system neoplasm	0.00139	0.00283	CcSEcCtD
Nedocromil—HSP90AA1—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.00139	0.00341	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.00139	0.00341	CbGpPWpGaD
Nedocromil—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00136	0.00277	CcSEcCtD
Nedocromil—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00135	0.00274	CcSEcCtD
Nedocromil—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00135	0.00274	CcSEcCtD
Nedocromil—Cough—Alitretinoin—peripheral nervous system neoplasm	0.00134	0.00272	CcSEcCtD
Nedocromil—CYSLTR2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00132	0.00325	CbGpPWpGaD
Nedocromil—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00132	0.00269	CcSEcCtD
Nedocromil—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00132	0.00269	CcSEcCtD
Nedocromil—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00132	0.00267	CcSEcCtD
Nedocromil—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00132	0.00267	CcSEcCtD
Nedocromil—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00131	0.00267	CcSEcCtD
Nedocromil—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00131	0.00267	CcSEcCtD
Nedocromil—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.00131	0.00265	CcSEcCtD
Nedocromil—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00131	0.00265	CcSEcCtD
Nedocromil—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00131	0.00265	CcSEcCtD
Nedocromil—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00131	0.00265	CcSEcCtD
Nedocromil—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00131	0.00265	CcSEcCtD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—PTPN11—peripheral nervous system neoplasm	0.0013	0.00319	CbGpPWpGaD
Nedocromil—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00129	0.00263	CcSEcCtD
Nedocromil—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00128	0.00259	CcSEcCtD
Nedocromil—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.00126	0.0031	CbGpPWpGaD
Nedocromil—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00125	0.00254	CcSEcCtD
Nedocromil—HSP90AA1—LKB1 signaling events—TP53—peripheral nervous system neoplasm	0.00124	0.00304	CbGpPWpGaD
Nedocromil—Eczema—Epirubicin—peripheral nervous system neoplasm	0.00124	0.00252	CcSEcCtD
Nedocromil—FPR1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.00124	0.00303	CbGpPWpGaD
Nedocromil—HSP90AA1—Class I PI3K signaling events mediated by Akt—AKT1—peripheral nervous system neoplasm	0.00124	0.00303	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—PTPN11—peripheral nervous system neoplasm	0.00123	0.00301	CbGpPWpGaD
Nedocromil—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00123	0.00249	CcSEcCtD
Nedocromil—Tremor—Cisplatin—peripheral nervous system neoplasm	0.00122	0.00249	CcSEcCtD
Nedocromil—CYSLTR1—Endothelins—HRAS—peripheral nervous system neoplasm	0.00122	0.00299	CbGpPWpGaD
Nedocromil—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00122	0.00247	CcSEcCtD
Nedocromil—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00122	0.00247	CcSEcCtD
Nedocromil—CYSLTR2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.00121	0.00298	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.00121	0.00298	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.00121	0.00297	CbGpPWpGaD
Nedocromil—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00121	0.00245	CcSEcCtD
Nedocromil—CYSLTR2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.0012	0.00295	CbGpPWpGaD
Nedocromil—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.0012	0.00244	CcSEcCtD
Nedocromil—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00119	0.00243	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.00119	0.00293	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—CD55—peripheral nervous system neoplasm	0.00119	0.00291	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.00118	0.00291	CbGpPWpGaD
Nedocromil—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00118	0.00241	CcSEcCtD
Nedocromil—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00118	0.00241	CcSEcCtD
Nedocromil—HSP90AA1—IL2 signaling events mediated by PI3K—AKT1—peripheral nervous system neoplasm	0.00118	0.0029	CbGpPWpGaD
Nedocromil—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.00117	0.00238	CcSEcCtD
Nedocromil—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00117	0.00238	CcSEcCtD
Nedocromil—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00117	0.00238	CcSEcCtD
Nedocromil—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00116	0.00236	CcSEcCtD
Nedocromil—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00115	0.00235	CcSEcCtD
Nedocromil—Eczema—Doxorubicin—peripheral nervous system neoplasm	0.00115	0.00233	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.00114	0.00281	CbGpPWpGaD
Nedocromil—HSP90AA1—Class I PI3K signaling events—HRAS—peripheral nervous system neoplasm	0.00114	0.00281	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00114	0.0028	CbGpPWpGaD
Nedocromil—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00114	0.00231	CcSEcCtD
Nedocromil—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00113	0.0023	CcSEcCtD
Nedocromil—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00113	0.0023	CcSEcCtD
Nedocromil—HSP90AA1—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	0.00112	0.00276	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—IFNB1—peripheral nervous system neoplasm	0.00112	0.00275	CbGpPWpGaD
Nedocromil—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.00112	0.00227	CcSEcCtD
Nedocromil—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00112	0.00227	CcSEcCtD
Nedocromil—CYSLTR2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.00111	0.00272	CbGpPWpGaD
Nedocromil—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.0011	0.00224	CcSEcCtD
Nedocromil—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.0011	0.00224	CcSEcCtD
Nedocromil—Dizziness—Topotecan—peripheral nervous system neoplasm	0.0011	0.00224	CcSEcCtD
Nedocromil—CYSLTR1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.0011	0.0027	CbGpPWpGaD
Nedocromil—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00109	0.00222	CcSEcCtD
Nedocromil—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00109	0.00222	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00108	0.0022	CcSEcCtD
Nedocromil—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00108	0.00219	CcSEcCtD
Nedocromil—CYSLTR1—Endothelins—AKT1—peripheral nervous system neoplasm	0.00108	0.00264	CbGpPWpGaD
Nedocromil—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00107	0.00218	CcSEcCtD
Nedocromil—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00107	0.00217	CcSEcCtD
Nedocromil—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00107	0.00217	CcSEcCtD
Nedocromil—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00107	0.00217	CcSEcCtD
Nedocromil—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00107	0.00217	CcSEcCtD
Nedocromil—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00106	0.00215	CcSEcCtD
Nedocromil—CYSLTR1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.00105	0.00258	CbGpPWpGaD
Nedocromil—HSP90AA1—Corticotropin-releasing hormone—CASP3—peripheral nervous system neoplasm	0.00105	0.00258	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—CASP3—peripheral nervous system neoplasm	0.00105	0.00258	CbGpPWpGaD
Nedocromil—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00105	0.00213	CcSEcCtD
Nedocromil—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00105	0.00213	CcSEcCtD
Nedocromil—Rash—Topotecan—peripheral nervous system neoplasm	0.00105	0.00213	CcSEcCtD
Nedocromil—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00105	0.00213	CcSEcCtD
Nedocromil—HSP90AA1—Regulation of Telomerase—MYC—peripheral nervous system neoplasm	0.00105	0.00257	CbGpPWpGaD
Nedocromil—Cough—Etoposide—peripheral nervous system neoplasm	0.00104	0.00212	CcSEcCtD
Nedocromil—Headache—Topotecan—peripheral nervous system neoplasm	0.00104	0.00212	CcSEcCtD
Nedocromil—Rash—Tretinoin—peripheral nervous system neoplasm	0.00104	0.00212	CcSEcCtD
Nedocromil—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00104	0.00212	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00104	0.00212	CcSEcCtD
Nedocromil—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00104	0.00211	CcSEcCtD
Nedocromil—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00104	0.00211	CcSEcCtD
Nedocromil—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00104	0.00211	CcSEcCtD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	0.00104	0.00254	CbGpPWpGaD
Nedocromil—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00104	0.00211	CcSEcCtD
Nedocromil—FPR1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.00104	0.00254	CbGpPWpGaD
Nedocromil—Headache—Tretinoin—peripheral nervous system neoplasm	0.00103	0.0021	CcSEcCtD
Nedocromil—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00103	0.0021	CcSEcCtD
Nedocromil—Pain—Vincristine—peripheral nervous system neoplasm	0.00103	0.0021	CcSEcCtD
Nedocromil—Rash—Melphalan—peripheral nervous system neoplasm	0.00103	0.00209	CcSEcCtD
Nedocromil—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00103	0.00209	CcSEcCtD
Nedocromil—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00102	0.00208	CcSEcCtD
Nedocromil—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00102	0.00207	CcSEcCtD
Nedocromil—HSP90AA1—Integrin-linked kinase signaling—AKT1—peripheral nervous system neoplasm	0.00101	0.00248	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.001	0.00245	CbGpPWpGaD
Nedocromil—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000994	0.00202	CcSEcCtD
Nedocromil—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000994	0.00202	CcSEcCtD
Nedocromil—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000989	0.00201	CcSEcCtD
Nedocromil—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000989	0.00201	CcSEcCtD
Nedocromil—Nausea—Topotecan—peripheral nervous system neoplasm	0.000989	0.00201	CcSEcCtD
Nedocromil—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000986	0.002	CcSEcCtD
Nedocromil—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000981	0.00199	CcSEcCtD
Nedocromil—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000981	0.00199	CcSEcCtD
Nedocromil—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000977	0.00198	CcSEcCtD
Nedocromil—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000968	0.00197	CcSEcCtD
Nedocromil—Nausea—Melphalan—peripheral nervous system neoplasm	0.000968	0.00197	CcSEcCtD
Nedocromil—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000963	0.00196	CcSEcCtD
Nedocromil—CYSLTR1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000962	0.00236	CbGpPWpGaD
Nedocromil—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000953	0.00194	CcSEcCtD
Nedocromil—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000953	0.00194	CcSEcCtD
Nedocromil—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000953	0.00194	CcSEcCtD
Nedocromil—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000951	0.00193	CcSEcCtD
Nedocromil—FPR1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.00094	0.00231	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000937	0.0023	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000937	0.0023	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—PTPN11—peripheral nervous system neoplasm	0.000929	0.00228	CbGpPWpGaD
Nedocromil—HSP90AA1—Validated targets of C-MYC transcriptional activation—MYC—peripheral nervous system neoplasm	0.000929	0.00228	CbGpPWpGaD
Nedocromil—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000926	0.00188	CcSEcCtD
Nedocromil—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000924	0.00188	CcSEcCtD
Nedocromil—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000922	0.00187	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000921	0.00187	CcSEcCtD
Nedocromil—CYSLTR1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.000917	0.00225	CbGpPWpGaD
Nedocromil—Pain—Cisplatin—peripheral nervous system neoplasm	0.000912	0.00185	CcSEcCtD
Nedocromil—PTGDR—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000908	0.00223	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000905	0.00222	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000905	0.00222	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	0.0009	0.00221	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000898	0.0022	CbGpPWpGaD
Nedocromil—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000898	0.00182	CcSEcCtD
Nedocromil—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000895	0.00182	CcSEcCtD
Nedocromil—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000891	0.00181	CcSEcCtD
Nedocromil—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000888	0.00181	CcSEcCtD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—NRAS—peripheral nervous system neoplasm	0.000883	0.00217	CbGpPWpGaD
Nedocromil—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000882	0.00179	CcSEcCtD
Nedocromil—PTGDR—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000874	0.00214	CbGpPWpGaD
Nedocromil—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000871	0.00177	CcSEcCtD
Nedocromil—HSP90AA1—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000866	0.00212	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—PPP3R1—peripheral nervous system neoplasm	0.000866	0.00212	CbGpPWpGaD
Nedocromil—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000865	0.00176	CcSEcCtD
Nedocromil—FPR1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000864	0.00212	CbGpPWpGaD
Nedocromil—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000864	0.00175	CcSEcCtD
Nedocromil—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000858	0.00174	CcSEcCtD
Nedocromil—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000857	0.00174	CcSEcCtD
Nedocromil—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000856	0.00174	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—PTPN11—peripheral nervous system neoplasm	0.000854	0.0021	CbGpPWpGaD
Nedocromil—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000851	0.00173	CcSEcCtD
Nedocromil—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000843	0.00171	CcSEcCtD
Nedocromil—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000843	0.00171	CcSEcCtD
Nedocromil—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000842	0.00171	CcSEcCtD
Nedocromil—CYSLTR1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.000841	0.00206	CbGpPWpGaD
Nedocromil—Pain—Etoposide—peripheral nervous system neoplasm	0.000835	0.0017	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000835	0.00205	CbGpPWpGaD
Nedocromil—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000835	0.0017	CcSEcCtD
Nedocromil—CYSLTR1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	0.000833	0.00204	CbGpPWpGaD
Nedocromil—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000828	0.00168	CcSEcCtD
Nedocromil—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000828	0.00168	CcSEcCtD
Nedocromil—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000825	0.00168	CcSEcCtD
Nedocromil—FPR1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000822	0.00202	CbGpPWpGaD
Nedocromil—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000806	0.00164	CcSEcCtD
Nedocromil—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000802	0.00163	CcSEcCtD
Nedocromil—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000799	0.00162	CcSEcCtD
Nedocromil—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000799	0.00162	CcSEcCtD
Nedocromil—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000797	0.00162	CcSEcCtD
Nedocromil—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000796	0.00162	CcSEcCtD
Nedocromil—PTGDR—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000794	0.00195	CbGpPWpGaD
Nedocromil—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000789	0.0016	CcSEcCtD
Nedocromil—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000788	0.0016	CcSEcCtD
Nedocromil—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000786	0.0016	CcSEcCtD
Nedocromil—CYSLTR2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000785	0.00192	CbGpPWpGaD
Nedocromil—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000784	0.00159	CcSEcCtD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—NRAS—peripheral nervous system neoplasm	0.000782	0.00192	CbGpPWpGaD
Nedocromil—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000776	0.00158	CcSEcCtD
Nedocromil—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000773	0.00157	CcSEcCtD
Nedocromil—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000772	0.00157	CcSEcCtD
Nedocromil—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000772	0.00157	CcSEcCtD
Nedocromil—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000772	0.00157	CcSEcCtD
Nedocromil—HSP90AA1—Integrins in angiogenesis—AKT1—peripheral nervous system neoplasm	0.000772	0.00189	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000771	0.00189	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	0.000769	0.00189	CbGpPWpGaD
Nedocromil—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000767	0.00156	CcSEcCtD
Nedocromil—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000765	0.00155	CcSEcCtD
Nedocromil—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000765	0.00155	CcSEcCtD
Nedocromil—HSP90AA1—Validated targets of C-MYC transcriptional activation—TP53—peripheral nervous system neoplasm	0.000763	0.00187	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	0.000762	0.00187	CbGpPWpGaD
Nedocromil—Rash—Vincristine—peripheral nervous system neoplasm	0.00076	0.00154	CcSEcCtD
Nedocromil—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00076	0.00154	CcSEcCtD
Nedocromil—Headache—Vincristine—peripheral nervous system neoplasm	0.000755	0.00153	CcSEcCtD
Nedocromil—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000745	0.00151	CcSEcCtD
Nedocromil—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000743	0.00151	CcSEcCtD
Nedocromil—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000743	0.00151	CcSEcCtD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—TP53—peripheral nervous system neoplasm	0.00074	0.00182	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by VEGF—NRAS—peripheral nervous system neoplasm	0.000738	0.00181	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—ERBB2—peripheral nervous system neoplasm	0.000734	0.0018	CbGpPWpGaD
Nedocromil—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00073	0.00148	CcSEcCtD
Nedocromil—HSP90AA1—Regulation of Telomerase—AKT1—peripheral nervous system neoplasm	0.000726	0.00178	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling events mediated by VEGFR1 and VEGFR2—AKT1—peripheral nervous system neoplasm	0.000726	0.00178	CbGpPWpGaD
Nedocromil—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00072	0.00146	CcSEcCtD
Nedocromil—Nausea—Vincristine—peripheral nervous system neoplasm	0.000716	0.00146	CcSEcCtD
Nedocromil—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000715	0.00145	CcSEcCtD
Nedocromil—CYSLTR2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000712	0.00175	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.00071	0.00174	CbGpPWpGaD
Nedocromil—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000708	0.00144	CcSEcCtD
Nedocromil—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000701	0.00142	CcSEcCtD
Nedocromil—HSP90AA1—Immune System—CD55—peripheral nervous system neoplasm	0.000691	0.0017	CbGpPWpGaD
Nedocromil—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000687	0.0014	CcSEcCtD
Nedocromil—CYSLTR2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000686	0.00168	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—AURKA—peripheral nervous system neoplasm	0.000681	0.00167	CbGpPWpGaD
Nedocromil—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000678	0.00138	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—ERBB2—peripheral nervous system neoplasm	0.000675	0.00166	CbGpPWpGaD
Nedocromil—Rash—Cisplatin—peripheral nervous system neoplasm	0.000672	0.00137	CcSEcCtD
Nedocromil—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000672	0.00136	CcSEcCtD
Nedocromil—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000668	0.00136	CcSEcCtD
Nedocromil—HSP90AA1—Disease—GNS—peripheral nervous system neoplasm	0.000665	0.00163	CbGpPWpGaD
Nedocromil—CYSLTR2—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.000658	0.00161	CbGpPWpGaD
Nedocromil—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000657	0.00134	CcSEcCtD
Nedocromil—CYSLTR2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000655	0.00161	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000649	0.00159	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000649	0.00159	CbGpPWpGaD
Nedocromil—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000646	0.00131	CcSEcCtD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—HRAS—peripheral nervous system neoplasm	0.000646	0.00158	CbGpPWpGaD
Nedocromil—HSP90AA1—EPH-Ephrin signaling—HRAS—peripheral nervous system neoplasm	0.000635	0.00156	CbGpPWpGaD
Nedocromil—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000633	0.00129	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000627	0.00154	CbGpPWpGaD
Nedocromil—HSP90AA1—Glucocorticoid receptor regulatory network—AKT1—peripheral nervous system neoplasm	0.000625	0.00153	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	0.000624	0.00153	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000623	0.00153	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000622	0.00153	CbGpPWpGaD
Nedocromil—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000621	0.00126	CcSEcCtD
Nedocromil—Rash—Etoposide—peripheral nervous system neoplasm	0.000616	0.00125	CcSEcCtD
Nedocromil—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000615	0.00125	CcSEcCtD
Nedocromil—Headache—Etoposide—peripheral nervous system neoplasm	0.000612	0.00124	CcSEcCtD
Nedocromil—HSP90AA1—Cell Cycle—CHEK2—peripheral nervous system neoplasm	0.000609	0.00149	CbGpPWpGaD
Nedocromil—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000608	0.00124	CcSEcCtD
Nedocromil—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000601	0.00122	CcSEcCtD
Nedocromil—HSP90AA1—Innate Immune System—IFNB1—peripheral nervous system neoplasm	0.0006	0.00147	CbGpPWpGaD
Nedocromil—Cough—Epirubicin—peripheral nervous system neoplasm	0.000585	0.00119	CcSEcCtD
Nedocromil—Nausea—Etoposide—peripheral nervous system neoplasm	0.00058	0.00118	CcSEcCtD
Nedocromil—HSP90AA1—Axon guidance—MET—peripheral nervous system neoplasm	0.00058	0.00142	CbGpPWpGaD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—HRAS—peripheral nervous system neoplasm	0.000572	0.0014	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000571	0.0014	CbGpPWpGaD
Nedocromil—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000571	0.00116	CcSEcCtD
Nedocromil—HSP90AA1—Corticotropin-releasing hormone—AKT1—peripheral nervous system neoplasm	0.00057	0.0014	CbGpPWpGaD
Nedocromil—HSP90AA1—TNF alpha Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.00057	0.0014	CbGpPWpGaD
Nedocromil—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000559	0.00114	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by ERBB2—NRAS—peripheral nervous system neoplasm	0.000559	0.00137	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GNS—peripheral nervous system neoplasm	0.000557	0.00137	CbGpPWpGaD
Nedocromil—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000556	0.00113	CcSEcCtD
Nedocromil—FPR1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000555	0.00136	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000552	0.00135	CbGpPWpGaD
Nedocromil—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000548	0.00111	CcSEcCtD
Nedocromil—CYSLTR1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	0.000544	0.00133	CbGpPWpGaD
Nedocromil—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000542	0.0011	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by VEGF—HRAS—peripheral nervous system neoplasm	0.00054	0.00133	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000536	0.00132	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000536	0.00132	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—NME1—peripheral nervous system neoplasm	0.000534	0.00131	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000529	0.0013	CbGpPWpGaD
Nedocromil—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000529	0.00107	CcSEcCtD
Nedocromil—HSP90AA1—Immune System—CD34—peripheral nervous system neoplasm	0.000524	0.00128	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—CDKN2A—peripheral nervous system neoplasm	0.000522	0.00128	CbGpPWpGaD
Nedocromil—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000517	0.00105	CcSEcCtD
Nedocromil—HSP90AA1—Metabolism—COX2—peripheral nervous system neoplasm	0.000514	0.00126	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—NRAS—peripheral nervous system neoplasm	0.000514	0.00126	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000511	0.00125	CbGpPWpGaD
Nedocromil—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000507	0.00103	CcSEcCtD
Nedocromil—HSP90AA1—VEGFA-VEGFR2 Pathway—AKT1—peripheral nervous system neoplasm	0.000505	0.00124	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PPP3R1—peripheral nervous system neoplasm	0.000504	0.00124	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	0.000494	0.00121	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	0.000494	0.00121	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000492	0.00121	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000492	0.00121	CbGpPWpGaD
Nedocromil—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000488	0.000992	CcSEcCtD
Nedocromil—FPR1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000486	0.00119	CbGpPWpGaD
Nedocromil—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000482	0.000979	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by VEGF—AKT1—peripheral nervous system neoplasm	0.000477	0.00117	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	0.000476	0.00117	CbGpPWpGaD
Nedocromil—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000473	0.000961	CcSEcCtD
Nedocromil—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000472	0.000959	CcSEcCtD
Nedocromil—PTGDR—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000469	0.00115	CbGpPWpGaD
Nedocromil—Pain—Epirubicin—peripheral nervous system neoplasm	0.000468	0.000951	CcSEcCtD
Nedocromil—HSP90AA1—Signaling Pathways—NTS—peripheral nervous system neoplasm	0.000466	0.00114	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PPP3R1—peripheral nervous system neoplasm	0.000465	0.00114	CbGpPWpGaD
Nedocromil—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	0.000456	0.00112	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000454	0.00111	CbGpPWpGaD
Nedocromil—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000452	0.000918	CcSEcCtD
Nedocromil—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000448	0.00091	CcSEcCtD
Nedocromil—HSP90AA1—Signaling Pathways—CD55—peripheral nervous system neoplasm	0.000447	0.0011	CbGpPWpGaD
Nedocromil—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000446	0.000906	CcSEcCtD
Nedocromil—HSP90AA1—Immune System—NCAM1—peripheral nervous system neoplasm	0.000445	0.00109	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—BIRC5—peripheral nervous system neoplasm	0.000442	0.00108	CbGpPWpGaD
Nedocromil—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000437	0.000889	CcSEcCtD
Nedocromil—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000437	0.000888	CcSEcCtD
Nedocromil—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000435	0.000884	CcSEcCtD
Nedocromil—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000433	0.00088	CcSEcCtD
Nedocromil—CYSLTR2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.000433	0.00106	CbGpPWpGaD
Nedocromil—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000433	0.00088	CcSEcCtD
Nedocromil—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000433	0.00088	CcSEcCtD
Nedocromil—CYSLTR1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	0.000432	0.00106	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—ERBB2—peripheral nervous system neoplasm	0.000424	0.00104	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000421	0.00103	CbGpPWpGaD
Nedocromil—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000414	0.000842	CcSEcCtD
Nedocromil—HSP90AA1—Developmental Biology—MET—peripheral nervous system neoplasm	0.000414	0.00101	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by ERBB2—HRAS—peripheral nervous system neoplasm	0.000409	0.001	CbGpPWpGaD
Nedocromil—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000403	0.00082	CcSEcCtD
Nedocromil—HSP90AA1—Disease—ENO2—peripheral nervous system neoplasm	0.000403	0.000989	CbGpPWpGaD
Nedocromil—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000403	0.000818	CcSEcCtD
Nedocromil—CYSLTR2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000401	0.000984	CbGpPWpGaD
Nedocromil—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000401	0.000814	CcSEcCtD
Nedocromil—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000401	0.000814	CcSEcCtD
Nedocromil—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000393	0.000798	CcSEcCtD
Nedocromil—HSP90AA1—Developmental Biology—PTPN11—peripheral nervous system neoplasm	0.000383	0.000939	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—HRAS—peripheral nervous system neoplasm	0.000376	0.000922	CbGpPWpGaD
Nedocromil—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000375	0.000761	CcSEcCtD
Nedocromil—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000373	0.000758	CcSEcCtD
Nedocromil—CYSLTR2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000368	0.000903	CbGpPWpGaD
Nedocromil—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000364	0.000739	CcSEcCtD
Nedocromil—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000362	0.000736	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by ERBB2—AKT1—peripheral nervous system neoplasm	0.000361	0.000885	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—VIP—peripheral nervous system neoplasm	0.000353	0.000866	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—IFNB1—peripheral nervous system neoplasm	0.000349	0.000857	CbGpPWpGaD
Nedocromil—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000348	0.000707	CcSEcCtD
Nedocromil—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.000704	CcSEcCtD
Nedocromil—Rash—Epirubicin—peripheral nervous system neoplasm	0.000345	0.000702	CcSEcCtD
Nedocromil—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000345	0.000701	CcSEcCtD
Nedocromil—FPR1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000344	0.000843	CbGpPWpGaD
Nedocromil—Headache—Epirubicin—peripheral nervous system neoplasm	0.000343	0.000697	CcSEcCtD
Nedocromil—CYSLTR1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000341	0.000837	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—PTPN11—peripheral nervous system neoplasm	0.000338	0.000829	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000338	0.000828	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000337	0.000828	CbGpPWpGaD
Nedocromil—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000335	0.000681	CcSEcCtD
Nedocromil—HSP90AA1—Signaling by EGFR in Cancer—AKT1—peripheral nervous system neoplasm	0.000332	0.000814	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.000332	0.000814	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	0.000327	0.000803	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	0.000326	0.0008	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000326	0.0008	CbGpPWpGaD
Nedocromil—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000325	0.000661	CcSEcCtD
Nedocromil—HSP90AA1—Disease—SLC2A1—peripheral nervous system neoplasm	0.000325	0.000797	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—NRAS—peripheral nervous system neoplasm	0.000322	0.000791	CbGpPWpGaD
Nedocromil—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000322	0.000655	CcSEcCtD
Nedocromil—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.000649	CcSEcCtD
Nedocromil—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.000649	CcSEcCtD
Nedocromil—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.000645	CcSEcCtD
Nedocromil—HSP90AA1—Developmental Biology—ERBB2—peripheral nervous system neoplasm	0.000302	0.000742	CbGpPWpGaD
Nedocromil—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000611	CcSEcCtD
Nedocromil—CYSLTR1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	0.0003	0.000736	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	0.000293	0.000718	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000292	0.000716	CbGpPWpGaD
Nedocromil—HSP90AA1—Cellular responses to stress—TP53—peripheral nervous system neoplasm	0.000291	0.000713	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000285	0.0007	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.000278	0.000682	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000272	0.000668	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—HGF—peripheral nervous system neoplasm	0.00027	0.000662	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—TH—peripheral nervous system neoplasm	0.000268	0.000658	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—ERBB2—peripheral nervous system neoplasm	0.000267	0.000655	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000267	0.000654	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.00026	0.000639	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000258	0.000632	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000256	0.000627	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000255	0.000626	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000251	0.000616	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	0.000245	0.000601	CbGpPWpGaD
Nedocromil—FPR1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000244	0.000599	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000243	0.000595	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000242	0.000594	CbGpPWpGaD
Nedocromil—PTGDR—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000236	0.000579	CbGpPWpGaD
Nedocromil—HSP90AA1—Axon guidance—HRAS—peripheral nervous system neoplasm	0.000236	0.000579	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000234	0.000574	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—NRAS—peripheral nervous system neoplasm	0.00023	0.000564	CbGpPWpGaD
Nedocromil—FPR1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000222	0.000544	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	0.000222	0.000544	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000219	0.000537	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000215	0.000527	CbGpPWpGaD
Nedocromil—PTGDR—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000214	0.000526	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	0.000209	0.000514	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—NRAS—peripheral nervous system neoplasm	0.000203	0.000498	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000203	0.000498	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000202	0.000496	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	0.0002	0.00049	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—MYC—peripheral nervous system neoplasm	0.000198	0.000487	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—PTPN11—peripheral nervous system neoplasm	0.000197	0.000483	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000196	0.000481	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.00019	0.000467	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000189	0.000464	CbGpPWpGaD
Nedocromil—CYSLTR2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000185	0.000454	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000183	0.00045	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.000183	0.000449	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000183	0.000448	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—PTPN11—peripheral nervous system neoplasm	0.000182	0.000446	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	0.00018	0.000443	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000177	0.000435	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—HRAS—peripheral nervous system neoplasm	0.000168	0.000413	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000168	0.000413	CbGpPWpGaD
Nedocromil—HSP90AA1—Cell Cycle—TP53—peripheral nervous system neoplasm	0.000163	0.0004	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—ERBB2—peripheral nervous system neoplasm	0.000156	0.000382	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.000155	0.000381	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000154	0.000377	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.00015	0.000368	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—HRAS—peripheral nervous system neoplasm	0.000149	0.000365	CbGpPWpGaD
Nedocromil—HSP90AA1—Developmental Biology—AKT1—peripheral nervous system neoplasm	0.000149	0.000365	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000148	0.000364	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—ERBB2—peripheral nervous system neoplasm	0.000144	0.000352	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000143	0.000352	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—MYC—peripheral nervous system neoplasm	0.000143	0.000351	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.00014	0.000344	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	0.000132	0.000324	CbGpPWpGaD
Nedocromil—HSP90AA1—Innate Immune System—AKT1—peripheral nervous system neoplasm	0.000131	0.000322	CbGpPWpGaD
Nedocromil—FPR1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	0.000131	0.000322	CbGpPWpGaD
Nedocromil—CYSLTR1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	0.000128	0.000315	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	0.000127	0.000312	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	0.000127	0.000312	CbGpPWpGaD
Nedocromil—PTGDR—Signaling Pathways—AKT1—peripheral nervous system neoplasm	0.000127	0.000311	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—NRAS—peripheral nervous system neoplasm	0.000118	0.00029	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—TP53—peripheral nervous system neoplasm	0.000118	0.000289	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	0.000117	0.000286	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000113	0.000276	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—NRAS—peripheral nervous system neoplasm	0.000109	0.000268	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.000107	0.000261	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—MYC—peripheral nervous system neoplasm	0.000102	0.00025	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	0.000101	0.000247	CbGpPWpGaD
Nedocromil—CYSLTR2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.93e-05	0.000244	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.93e-05	0.000244	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.13e-05	0.000224	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—HRAS—peripheral nervous system neoplasm	8.66e-05	0.000212	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.15e-05	0.0002	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—HRAS—peripheral nervous system neoplasm	7.99e-05	0.000196	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.8e-05	0.000191	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.65e-05	0.000188	CbGpPWpGaD
Nedocromil—HSP90AA1—Immune System—AKT1—peripheral nervous system neoplasm	7.64e-05	0.000188	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.13e-05	0.000175	CbGpPWpGaD
Nedocromil—HSP90AA1—Disease—AKT1—peripheral nervous system neoplasm	7.06e-05	0.000173	CbGpPWpGaD
Nedocromil—CYSLTR1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.89e-05	0.000169	CbGpPWpGaD
Nedocromil—HSP90AA1—Metabolism—AKT1—peripheral nervous system neoplasm	5.91e-05	0.000145	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.85e-05	0.000144	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.6e-05	0.000137	CbGpPWpGaD
Nedocromil—HSP90AA1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.94e-05	0.000121	CbGpPWpGaD
